Hypera Pharma (Xantinon Drug)

Business Data, Corporate Office and Headquarter Address

About

Hypera Pharma (Xantinon Drug) is Buildings and Property in Brazil that focus on Drug business. They cover business area such as Drug, liver disorder.

Business Type

Buildings and Property

Country

Brazil

Founded

-

Company Focus

Drug

Website

-

Corporate Office and Headquarter Office address:

Avenida Magalhaes de Castro, 4800
24° andar, Edifício Continental Tower, Bairro Cidade Jardim
Sao Paulo, SP 05502-001
Brazil

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

Drugliver disorder

* We use standard office opening hours in near Hypera Pharma (Xantinon Drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Hypera Pharma (Xantinon Drug) Frequently Asked Questions

What or who is Hypera Pharma (Xantinon Drug)?

Hypera Pharma (Xantinon Drug) is Buildings and Property business from Brazil that founded in - ( years old in ), Hypera Pharma (Xantinon Drug) business is focusing on Drug.

Where is Hypera Pharma (Xantinon Drug) headquarter and corporate office address?

Hypera Pharma (Xantinon Drug) headquarter office and corporate office address is located in Avenida Magalhaes de Castro, 4800 24° andar, Edifício Continental Tower, Bairro Cidade Jardim Sao Paulo, SP 05502-001 Brazil.

Where is Hypera Pharma (Xantinon Drug) country origins?

Hypera Pharma (Xantinon Drug) was founded in Brazil.

What is Drug business focus on?

In , Hypera Pharma (Xantinon Drug) is currently focus on Drug sector.

Drug Business Interest from Google Trend

Above is snippet of Google Trends for "Drug" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Hypera Pharma (Xantinon Drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.